Research Article | Open Access | Download PDF
Volume 16 | Issue 2 | Year 2026 | Article Id. IJBTT-V16I2P102 | DOI : https://doi.org/10.14445/22490183/IJBTT-V16I2P102Comparison of Choroidal Thickness in Controlled and Hypertensive Patients By Using OCT
Amara Nasir, Zunaira Nasir, Kanaza Razaq, Samina Rehman, Khushbakht Nasir
| Received | Revised | Accepted | Published |
|---|---|---|---|
| 07 May 2026 | 10 Jun 2026 | 29 Jun 2026 | 16 Jul 2026 |
Citation :
Amara Nasir, Zunaira Nasir, Kanaza Razaq, Samina Rehman, Khushbakht Nasir, "Comparison of Choroidal Thickness in Controlled and Hypertensive Patients By Using OCT," International Journal of Biotech Trends and Technology (IJBTT), vol. 16, no. 2, pp. 8-13, 2026. Crossref, https://doi.org/10.14445/22490183/IJBTT-V16I2P102
Abstract
The objective of the study was to assess the choroidal thickness in control and hypertensive patients. To check the effects of hypertension on the thickness of the choroid by using the instrument, Optical Coherence Tomography(OCT).Methodology: The study design was a Prospective comparative cross‑sectional study. 70 eyes of 35 subjects in the hypertensive group (A) and 70 eyes of 35 subjects in the control group (B) in the age group of 35–60 years were subjected. The thickness of the choroid was measured at the sub‑fovea region, nasal and temporal to the fovea, with enhanced depth imaging mode of OCT. Systolic and Diastolic blood pressure were measured. Results: The choroidal thickness at subfoveal, temporal and nasal to fovea was significantly(p value 0.001) decreased in the hypertensive group. Choroidal thickness at subfoveal, nasal and temporal to fovea (252.34 ± 53.94 μm, 248.25±65.47,249.21±64.27 respectively ) as compared to the control group choroidal thickness at subfoveal, nasal and temporal to fovea (305.35±54.78, 289.87±56.07, 298.50±54.06 respectively). Conclusion: The study showed that choroidal thickness was decreased in hypertensive subjects as compared to control subjects. We should check the choroidal thickness in hypertensive patients to reduce the chances of disease progression in the choroid.
Keywords
Choroid, Subfoveal, Choroidal Thickness, OCT, Hypertensive.
References
[1] Leonard
A. Levin, Paul L. Kaufman, and Mary Elizabeth Hartnett, Adler's Physiology
of the Eye E-Book, 12th ed., Elsevier Health Sciences,
2024.
[Google Scholar]
[Publisher Link]
[2] Tien
Y. Wong, and Paul Mitchell, “Hypertensive Retinopathy,” New England Journal
of Medicine, vol. 351, no. 22, pp. 2310-2317, 2004.
[CrossRef]
[Google Scholar]
[Publisher Link]
[3] Ramandeep
Singh et al., “Enhanced Depth Imaging Spectral Domain Optical Coherence
Tomography Versus Ultrasonography B-Scan for Measuring Retinochoroidal
Thickness in Normal Eyes,” Retina, vol. 35, no. 2, pp. 250-256, 2015.
[CrossRef]
[Google Scholar]
[Publisher Link]
[4] Ron
Margolis, and Richard F. Spaide, “A Pilot Study of Enhanced Depth Imaging
Optical Coherence Tomography of the Choroid in Normal Eyes,” American
Journal of Ophthalmology, vol. 147, no. 5, pp. 811-815, 2009.
[CrossRef]
[Google Scholar]
[Publisher Link]
[5] Richard
F. Spaide, Hideki Koizumi, and Maria C. Pozonni, “Enhanced Depth Imaging
Spectral-Domain Optical Coherence Tomography,” American Journal of
Ophthalmology, vol. 146, no. 4, pp. 496-500, 2008.
[CrossRef]
[Google Scholar]
[Publisher Link]
[6] Ibrahim
Tuncer et al., “Choroidal Thickness in Relation to Sex, Age, Refractive Error,
and Axial Length in Healthy Turkish Subjects,” International Ophthalmology,
vol. 35, no. 3, pp. 403-410, 2015.
[CrossRef]
[Google Scholar]
[Publisher Link]
[7] Ana
Sanchez-Cano et al., “Choroidal Thickness and Volume in Healthy Young White
Adults and the Relationships between them and Axial Length, Ammetropy and Sex,”
American Journal of Ophthalmology, vol. 158, no. 3, pp. 574-583, 2014.
[CrossRef]
[Google Scholar]
[Publisher Link]
[8] Fahrettin
Akay et al., “Choroidal Thickness in Systemic Arterial Hypertension,” European
Journal of Ophthalmology, vol. 26, no. 2, pp. 152-157, 2016.
[CrossRef]
[Google Scholar]
[Publisher Link]
[9] Paul
K. Whelton et al., “2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/ASH/ASPC/NMA/PCNA
Guideline for the Prevention, Detection, Evaluation, and Management of High
Blood Pressure in Adults: A Report of the American College of
Cardiology/American Heart Association Task Force on Clinical Practice
Guidelines,” Circulation, vol. 138, no. 17, pp. 484-594, 2018.
[CrossRef]
[Google Scholar]
[Publisher Link]
[10] Colin
S. Tan et al., “Diurnal Variation of Choroidal Thickness in Normal, Healthy
Subjects Measured by Spectral Domain Optical Coherence Tomography,” Investigative
Ophthalmology and Visual Science, vol. 53, no. 1, pp. 261-266, 2012.
[CrossRef]
[Google Scholar]
[Publisher Link]
[11] Takamitsu
Fujiwara et al., “Enhanced Depth Imaging Optical Coherence Tomography of the
Choroid in Highly Myopic Eyes,” American Journal of Ophthalmology, vol.
148, no. 3, pp. 445-450, 2009.
[CrossRef]
[Google Scholar]
[Publisher Link]
[12] R.M. Niknam et al., “Effect of Hypertension on
Foveolar Choroidal Haemodynamics,” British Journal of Ophthalmology,
vol. 88, no. 10, pp. 1263-1265, 2004.
[CrossRef]
[Google Scholar]
[Publisher Link]
[13] Ron
Margolis, and Richard F. Spaide, “A Pilot Study of Enhanced Depth Imaging
Optical Coherence Tomography of the Choroid in Normal Eyes,” American
Journal of Ophthalmology, vol. 147, no. 5, pp. 811-815, 2009.
[CrossRef]
[Google Scholar]
[Publisher Link]
[14] Jay
Chhablani et al., “Choroidal Thickness Profile in Healthy Indian Subjects,” Indian
Journal of Ophthalmology, vol. 62, no. 11, pp. 1060-1063, 2014.
[CrossRef]
[Google Scholar]
[Publisher Link]
[15] Luke
Thomas Sansom, Carlo A. Suter, and Martin McKibbin, “The Association Between
Systolic Blood Pressure, Ocular Perfusion Pressure and Subfoveal Choroidal
Thickness in Normal Individuals,” Acta Ophthalmologica, vol. 94, no. 2,
pp. 157-158, 2016.
[CrossRef]
[Google Scholar]
[Publisher Link]
[16] Mustafa
Gök et al., “Evaluation of Choroidal Thickness Via Enhanced Depth-Imaging
Optical Coherence Tomography in Patients with Systemic Hypertension,” Indian
Journal of Ophthalmology, vol. 63, no. 3, pp. 239-243, 2015.
[CrossRef]
[Google Scholar]
[Publisher Link]
[17] Craig Balmforth et al., “Chorioretinal
Thinning in Chronic Kidney Disease Links to Inflammation and Endothelial
Dysfunction,” JCI Insight, vol. 1, no. 20, pp. 1-13, 2016.
[CrossRef]
[Google Scholar]
[Publisher Link]
[18] Daniel
Velazquez-Villoria et al., “Swept Source Optical Coherence Tomography
Evaluation of Chorioretinal Changes in Hypertensive Choroidopathy Related to
HELLP Syndrome,” Retinal Cases and Brief Reports, vol. 13, no. 1, pp.
30-33, 2019.
[CrossRef]
[Google Scholar]
[Publisher Link]
[19] Mark
O.M. Tso, and Lee M. Jampol, “Pathophysiology of Hypertensive Retinopathy,” Ophthalmology,
vol. 89, no. 10, pp. 1132-1145, 1982.
[CrossRef]
[Google Scholar]
[Publisher Link]